You are here: Home Departments Other research Research projects Cognomics People Bart Kiemeney Biosketch

Cognomics -

Bart Kiemeney Biosketch

Lambertus A. (Bart) Kiemeney started his career as a physical therapist. He obtained his MSc in Biomedical Sciences (major in epidemiology) at the Radboud University Nijmegen (RUN), the Netherlands (1988). From 1988-1992, he acted as head of the cancer registry department of the Comprehensive Cancer Center IKO in Nijmegen. Simultaneously, he worked on his PhD thesis ‘Prognostic assessment of superficial bladder cancer’ at the Departments of Epidemiology and Urology of the RUN. During a 2-year postdoctoral fellowship from the Netherlands Cancer Society he obtained further training in clinical and genetic epidemiology at the University of Washington and the Fred Hutchinson Cancer Center, Seattle WA, and the Johns Hopkins University, Baltimore MD. In 1994, he returned to Nijmegen for a tenure track position in cancer epidemiology at the Departments of Epidemiology and Urology. In addition, he is part-time research director at the Comprehensive Cancer Center IKO, Nijmegen. In 2003, he was appointed professor of cancer epidemiology at the RUN. His main research interests lie in the genetic and clinical epidemiology of bladder and prostate cancer. He is active in several strong international collaborations (e.g. EPIC, EU 6th FP Polygene, EU 7th FP Promark, International Bladder Cancer Network, International Bladder Cancer Consortium), chair or (board) member of several national and international scientific advisory committees, and coordinator of a large EU 7th FP (EuroTARGET). Bart Kiemeney has (co) authored approx. 350 peer reviewed papers and 25 book chapters. He published the first genome wide association study of bladder cancer.

Recent key-publications by Bart Kiemeney:

1.       Gudmundsson J, ……., Jinga V, Mates D, Kiemeney LA, Neal DE, Thorsteinsdottir U, Rafnar T, Stefansson K. Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels. Sci Transl Med 2010 Dec 15 ;2 (62): 62ra92.

2.       Kiemeney LA, ....., Aben KKH, Jonsson E, Thorsteinsdottir U, Knowles MA, Rafnar T, Stefansson K. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat Genet 2010; 42(5): 415-9.

3.       Rafnar T, ……, Masson G, Kiemeney LA, Mayordomo JI, Thorsteinsdottir U, Stefansson K. Mutations in BRIP1 confer high risk of ovarian cancer. Nat Genet 2011 Oct 2;43(11):1104-7. doi: 10.1038/ng.955.

4.       Wu X, Ye Y, Kiemeney LA, Sulem P, ……, Thorsteinsdottir U, Aben KK, Witjes JA, Stefansson K, Amos CI, Karagas MR, Gu J. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet 2009; 41(9): 991-5. (Corrigendum: Nat Genet 2009 Oct;41(10):1156.)

5.       Kiemeney LA, …….., Thorsteinsdottir U, Kong A, Rafnar T, Stefansson K. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 2008; 40(11): 1307-1312.

Last checked 2016-07-18 by Martina Bernhard

Street address
Wundtlaan 1
6525 XD Nijmegen
The Netherlands


Mailing address
P.O. Box 310
6500 AH Nijmegen
The Netherlands

Phone:   +31-24-3521911
Fax:        +31-24-3521213
E-mail:   


Public Outreach Officer
Charlotte Horn